» Articles » PMID: 30469430

The Role of Long Noncoding RNAs in Diabetic Alzheimer's Disease

Overview
Journal J Clin Med
Specialty General Medicine
Date 2018 Nov 25
PMID 30469430
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) are involved in diverse physiological and pathological processes by modulating gene expression. They have been found to be dysregulated in the brain and cerebrospinal fluid of patients with neurodegenerative diseases, and are considered promising therapeutic targets for treatment. Among the various neurodegenerative diseases, diabetic Alzheimer's disease (AD) has been recently emerging as an important issue due to several unexpected reports suggesting that metabolic issues in the brain, such as insulin resistance and glucose dysregulation, could be important risk factors for AD. To facilitate understanding of the role of lncRNAs in this field, here we review recent studies on lncRNAs in AD and diabetes, and summarize them with different categories associated with the pathogenesis of the diseases including neurogenesis, synaptic dysfunction, amyloid beta accumulation, neuroinflammation, insulin resistance, and glucose dysregulation. It is essential to understand the role of lncRNAs in the pathogenesis of diabetic AD from various perspectives for therapeutic utilization of lncRNAs in the near future.

Citing Articles

The roles of long non-coding RNAs in Alzheimer's disease diagnosis, treatment, and their involvement in Alzheimer's disease immune responses.

Wu X, Xia P, Yang L, Lu C, Lu Z Noncoding RNA Res. 2024; 9(3):659-666.

PMID: 38577023 PMC: 10987299. DOI: 10.1016/j.ncrna.2024.03.008.


Insights into the mechanisms of non-coding RNAs' implication in the pathogenesis of Alzheimer's disease.

Khodayi-Shahrak M, Khalaj-Kondori M, Feizi M, Talebi M EXCLI J. 2022; 21:921-940.

PMID: 36110561 PMC: 9441681. DOI: 10.17179/excli2022-5006.


Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology.

Nukala S, Jousma J, Cho Y, Lee W, Ong S Cell Biosci. 2022; 12(1):24.

PMID: 35246252 PMC: 8895873. DOI: 10.1186/s13578-022-00757-y.


Uncharacterized RNAs in Plasma of Alzheimer's Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power.

Barbagallo C, Di Martino M, Grasso M, Salluzzo M, Scionti F, Cosentino F Int J Mol Sci. 2020; 21(20).

PMID: 33076555 PMC: 7588983. DOI: 10.3390/ijms21207644.


Transcriptional Networks of Microglia in Alzheimer's Disease and Insights into Pathogenesis.

Chew G, Petretto E Genes (Basel). 2019; 10(10).

PMID: 31614849 PMC: 6826883. DOI: 10.3390/genes10100798.

References
1.
Zhong J, Chuang S, Bianchi R, Zhao W, Lee H, Fenton A . BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J Neurosci. 2009; 29(32):9977-86. PMC: 2866649. DOI: 10.1523/JNEUROSCI.3893-08.2009. View

2.
Heneka M, Carson M, El Khoury J, Landreth G, Brosseron F, Feinstein D . Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405. PMC: 5909703. DOI: 10.1016/S1474-4422(15)70016-5. View

3.
Yang C, Li X, Wang Y, Zhao L, Chen W . Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene. 2012; 496(1):8-16. DOI: 10.1016/j.gene.2012.01.012. View

4.
Lee J, Barral S, Reitz C . The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease. Curr Neurol Neurosci Rep. 2008; 8(5):384-91. PMC: 2694663. DOI: 10.1007/s11910-008-0060-8. View

5.
Kang M, Abdelmohsen K, Hutchison E, Mitchell S, Grammatikakis I, Guo R . HuD regulates coding and noncoding RNA to induce APP→Aβ processing. Cell Rep. 2014; 7(5):1401-1409. PMC: 4074355. DOI: 10.1016/j.celrep.2014.04.050. View